Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Oxycodone Hydrochloride Sustained-release Tablets in the Treatment of Moderate to Severe Cancer Pain：A Multicenter Real World Study

NCT05962294 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05962294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Oxycodone Hydrochloride Sustained-release Tablets in the Treatment of Moderate to Severe Cancer Pain：A Multicenter Real World Study
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
July 31, 2024
Enrollment
916 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain, oxycodone, real-world study